Regulation of human placental progesterone synthesis in vitro by naturally occurring steroids

Abstract

A regulatory model of human placental progesterone synthesis is based on studies with isolated placental enzymes. Steroids causing a dose-dependent inhibition are listed in the standing order of their inhibitory potency (I 50(μM)/ K 1 value (μM)/type of inhibition: c = competitive and nc = non competitive). Cholesterol side chain cleavage enzyme (mitochondria): Mainly regulated by hydroxylated cholesterol derivates. No inhibition was observed by cholesterylesters and by other naturally occurring steroids tested. 5-ene-3β-hydroxysteroid dehydrogenase-isomerase (mitochondria): 6β-hydroxyprogesterone (nc), dehydroepiandrosterone (0.32/0.82/c), 20α-dihydroprogesterone (0.38/-/nc), progesterone (0.46/-), estrone (0.56/0.1/c), estradiol (0.1/0.8/c), 17α-hydroxyprogesterone (2.1/-/nc), 17α-hydroxypregnenolone (0.4/-/C), dehydroepiandrosterone sulfate (2.5/-/e), cortisone (5.0/-), cortisol (100/-). 20α-hydroxysteroid dehydrogenase (cytoplasmic): estrone (0.26/0.7/c), estradiol (0.28/0.9/c), pregnenolone (4.4/9.2/c), 5α-pregnan-3β-ol-20-one (4.6/-/nc), estriol (5.1/11.5/c), dehydroepiandrosterone (7.2/14.0/c), 5α-dihydrotestosterone (26.0/-/nc), progesterone (33.0/48.0/c), dehydroepiandrosterone sulfate (50.0/23.0/nc), and testosterone (59.0/63.0/c). An autoregulatory mechanism of placental progesterone synthesis is postulated which is in good agreement with data published by others proving that placental progesterone synthesis is independent of the endocrine organs of the mother and the fetus.